FGF10 Therapeutic Administration Promotes Mobilization of Injury-Activated Alveolar Progenitors in a Mouse Fibrosis Model

Idiopathic pulmonary fibrosis (IPF) is a devastating interstitial lung disease with dire consequences and in urgent need of improved therapies. Compelling evidence indicates that damage or dysfunction of AT2s is of central importance in the development of IPF. We recently identified a novel AT2 subp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Yu-Qing, Cai, Ge-Fu, Zeng, Ping-Ping, Dhlamini, Qhaweni, Chen, Le-Fu, Chen, Jun-Jie, Lyu, Han-Deng, Mossahebi-Mohammadi, Majid, Ahmadvand, Negah, Bellusci, Saverio, Li, Xiaokun, Chen, Chengshui, Zhang, Jin-San
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368687/
https://www.ncbi.nlm.nih.gov/pubmed/35954241
http://dx.doi.org/10.3390/cells11152396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368687/
https://www.ncbi.nlm.nih.gov/pubmed/35954241
http://dx.doi.org/10.3390/cells11152396

Ejemplares similares